Citations

Clear

959 citation(s) found for "Service, F J".

What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
Croome, Kristopher P. , Lee, David D. , Pungpapong, Surakit , Taner, C. Burcin , Croome, Kris P , Lee, David D , Pungpapong, Surakit , Keaveny, Andrew P.

Mayo Clinic

Liver Transplantation | January 17, 2018 | Volume: 24 | Issue: 4 | Pages: 497-504

10.1002/lt.25009 | PMID 29341398 Get It

The tragedy of the national opioid epidemic has resulted in a significant increase in the number of opioid‐related deaths and accordingly an increase in the number of potential donors designated Public Health Service (PHS) increased risk. Previous studies have demonstrated reluctance to use these PHS organs, and as a result, higher discard rates for these organs have been observed. All patients listed for liver transplantation in the United States from January 2005 to December 2016 were investigated. Patients on the waiting list were divided into 2 groups: those in which a PHS liver was used for transplantation (accepted PHS group) and those in which a PHS liver was declined and transplanted into a recipient lower on the match run (declined PHS group). Intention‐to‐treat patient survival from the time of PHS offer was significantly higher in the accepted PHS compared with the declined PHS group (P < 0.001). On Cox multivariate regression, declining a PHS donor liver was associated with a hazard ratio of 2.36 (95% confidence interval, 2.23‐2.49; P < 0.001). For patients in which a PHS organ offer was declined, 11.6% died or were delisted for being too sick within the subsequent year. Donor liver allografts implanted in the accepted PHS group were of a lower donor risk index (1.28 versus 1.44) compared with the non‐PHS organs that patients in the declined PHS group ultimately received if they underwent transplantation. In conclusion, there is a significantly higher survival for patients in which a PHS liver is accepted and used compared with those patients in which a PHS organ is declined. These data will help inform decisions about whether or not to accept a PHS donor liver for both patients and transplant professionals. Liver Transplantation 24 497–504 2018 AASLD.
Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC)
Jenkins, Mark A. , Win, Aung Ko , Templeton, Allyson , Angelakos, Maggie S, Buchanan, Daniel D. , Cotterchio, Michelle , Figueiredo, Jane C. , Thibodeau, Stephen N. , Gallinger, Steven, Lindor, Noralane M. , Haile, Robert W. , Investigators, Colon Cancer Family Registry Cohort, Ahnen, Dennis J. , Anton, Kristen , Arnold, Julie, Aronson, Melyssa , Aujard, Kelly, Bapat, Bharati , Barker, Melissa, Bickerstaffe, Adrian , Burnett, Terrilea, Daftary, Darshana, DeRycke, Melissa S. , Dicks, Elizabeth , Diep, Anh, Duggan, Dave , Fisher, Douglass, Fox, Samantha , French, Amy J. , Glanz, Karen, Goldblatt, Jack, Goldberg, Richard M. , Goode, Ellen L. , Greenberg, Cary, Green, Jane , Green, Roger, Grove, John H. , Gryfe, Robert, Harmon, Patricia, Holowaty, Eric J., Holter, Spring, Kim, Hyeja, Kirk, Judy, Lance, Peter , Laurino, Mercy , Leggett, Barbara , Levine, A. Joan, Lowery, Jan T. , Lydum, Laurie, Madlensky, Lisa , Makar, Karen , Maskiell, Judi, McAllister, Pamela K., McGannon, Ellen, McKeown‐Eyssen, Gail, McLaughlin, John, Miller-Pakvasa, Heide, Nguyen, Nathalie , Nigon, Sandy, Parafrey, Patrick, Parry, Susan, Peterson, Susan K. , Phipps, Amanda I. , Redston, Mark , Rogers, Scott O., Schully, Sheri D. , Selander, Teresa, Seminara, Daniella, Shiovitz, Stacey, Siegmund, Kim, Smyrk, Thomas C. , Snazel, Douglas, Stubbs, John, Suthers, Graeme , Thomas, Duncan C. , West, D. P., Woods, Michael O. , Younghusband, Ban, Young, Joanne , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Baron, John A. , Potter, John D. , Hopper, John L. , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Investigators, Colon Cancer Family Registry Cohort, Cheng, Iona C. , Church, James M. , Church, Timothy R. , Clendenning, Mark , Esplen, Mary Jane , Giles, Graham G. , Grady, William M. , Keogh, Louise Anne , Limburg, Paul J. , Macrae, Finlay , Malen, Rachel C. , McLaughlin, John, Möslein, Gabriela , Pollett, Aaron F. , Sandler, Robert David , Southey, Melissa C. , Tucker, Kathy

Mayo Clinic

International Journal of Epidemiology | January 16, 2018 | Volume: 47 | Issue: 2 | Pages: 387-388i

10.1093/ije/dyy006 | PMID 29490034 Get It

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Samson, Adel , Scott, Karen J. , Taggart, David J. , Wilson, Erica , Nuovo, Gerard J. , Thomson, Simon , Mathew, Ryan , Fuller, Martin, Kottke, Timothy, Thompson, Jill , Ilett, Elizabeth J. , Cockle, Julia , Hille, Philip van, Sivakumar, Gnanamurthy, Polson, Euan S. , Turnbull, Samantha , Appleton, Elizabeth , Migneco, G , Rose, Ailsa , Coffey, Matthew, Beirne, Deborah , Collinson, Fiona , Ralph, Christy , Anthoney, Alan , Twelves, Christopher , Furness, Andrew J.S. , Quezada, Sergio A. , Wurdak, Heiko , Errington‐Mais, Fiona , Pandha, Hardev , Harrington, Kevin J. , Selby, Peter J. , Vile, Richard G. , Griffin, Stephen , Stead, Lucy F. , Short, Susan , Melcher, Alan , Taggart, David , Wilson, Erica , Nuovo, Gerard J , Thomson, Simon , Mathew, Ryan K , Kottke, Timothy J, Thompson, Jill M, Ilett, Elizabeth J , Cockle, Julia V , Turnbull, Samantha J , Rose, Ailsa S , Beirne, Deborah A , Ralph, Christy , Alan Anthoney, D , Quezada, Sergio A , Wurdak, Heiko , Errington-Mais, Fiona , Selby, Peter J , Griffin, Stephen , Stead, Lucy F , Short, Susan C , Melcher, Alan A , Harrington, Kevin , West, Emma J. , Corns, Robert A. , Appleton, Elizabeth

Mayo Clinic

Science Translational Medicine | January 3, 2018 | Volume: 10 | Issue: 422 | Pages: No page available

10.1126/scitranslmed.aam7577 | PMID 29298869 Get It

Intravenous infusion of oncolytic reovirus in patients leads to infection of brain tumors, infiltration by cytotoxic T cells, and up-regulation of PD-L1.
Predictors of Urology Resident Surgical Skills, Clinical Communication Skills, Common Sense and In-Service Scores
Thompson, R. Houston, Lohse, Christine M. , Husmann, Douglas A. , Leibovich, Bradley C. , Gettman, Matthew T.

Mayo Clinic

Urology Practice | December 29, 2017 | Volume: 6 | Issue: 1 | Pages: 52-57

10.1016/j.urpr.2017.12.002 | PMID 37312349 Get It

Intracranial metastasis in fibrolamellar hepatocellular carcinoma
Hammond, William J. , Saltsman, James A. , Farber, Benjamin A. , Danzer, Enrico , Sherpa, Tshering C., Banda, Charles D., Andolina, Jeffrey R. , Karimi, Sasan , Brennan, Cameron , LaQuaglia, Michael P. , Simon, Sanford M. , Farber, Benjamin A , Hammond, William J , LaQuaglia, Michael P , Simon, Sanford M , Lalazar, Gadi , Torbenson, Michael

Mayo Clinic

Pediatric Blood & Cancer | December 29, 2017 | Volume: 65 | Issue: 4 | Pages: No page available

10.1002/pbc.26919 | PMID 29286561 Get It

AbstractFibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver malignancy in adolescents and young adults. Surgery is the mainstay of therapy for primary and metastatic disease. Most patients relapse, with development of both local and distant metastases. Brain metastases from solid tumors are rare in the pediatric and young adult population. Here, we document three patients with brain metastases from FLHCC, confirmed by histology and molecular characterization of the chimeric fusion DNAJB1–PRKACA, each necessitating neurosurgical intervention. These observations highlight the ability of FLHCC to metastasize to the brain and suggest the need for surveillance neuroimaging for patients with advanced‐stage disease.
Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction
Huang, Yu-Li, Bryce, Alan H. , Culbertson, Tracy, Connor, Sarah L., Looker, Sherry, Altman, Kristin M., Collins, James , Stellner, Winston, Moreno‐Aspitia, Alvaro , Looker, Sherry A, Collins, James G, McWilliams, Robert R. , Bryce, Alan H , Culbertson, Tracy L, Ailawadhi, Sikander , Mesa, Ruben A.

Mayo Clinic

Journal of Oncology Practice | December 22, 2017 | Volume: 14 | Issue: 2 | Pages: e82-e91

10.1200/jop.2017.025510 | PMID 29272201 Get It

Introduction: Optimal scheduling and calendar management in an outpatient chemotherapy unit is a complex process that is driven by a need to focus on safety while accommodating a high degree of variability. Primary constraints are infusion times, staffing resources, chair availability, and unit hours. Methods: We undertook a process to analyze our existing management models across multiple practice settings in our health care system, then developed a model to optimize safety and efficiency. The model was tested in one of the community chemotherapy units. We assessed staffing violations as measured by nurse-to-patient ratios throughout the workday and at key points during treatment. Staffing violations were tracked before and after the implementation of the new model. Results: The new model reduced staffing violations by nearly 50% and required fewer chairs to treat the same number of patients for the selected clinic day. Actual implementation results indicated that the new model leveled the distribution of patients across the workday with an 18% reduction in maximum chair utilization and a 27% reduction in staffing violations. Subsequently, a positive impact on peak pharmacy workload reduced delays by as much as 35 minutes. Nursing staff satisfaction with the new model was positive. Conclusion: We conclude that the proposed optimization approach with regard to nursing resource assignment and workload balance throughout a day effectively improves patient service quality and staff satisfaction.
Mechanical modulation of pressure-volume characteristics of contracted canine airways in vitro
Stropp, J. Q., Service, J., Gunst, Susan J.

Mayo Clinic

Journal of Applied Physiology | December 21, 2017 | Volume: 68 | Issue: 5 | Pages: 2223-2229

10.1152/jappl.1990.68.5.2223 | PMID 2361927 Get It

In normal humans and dogs, the airways do not constrict to closure even when maximally stimulated. However, airway closure can be produced in isolated canine lobes and bronchial segments that are stimulated with maximal concentrations of bronchoconstrictors. These observations suggest that under normal conditions, physiological mechanisms to limit bronchoconstriction exist in vivo. In this investigation, we evaluated how mechanical factors that influence airway smooth muscle contractility contribute to the modulation of the pressure-volume characteristics of contracted canine intraparenchymal airways in vitro. Our results demonstrated that maximal and even submaximal contractile stimuli can produce airway closure in bronchi that are allowed to contract under isobaric conditions. However, the effectiveness of bronchoconstrictors is significantly reduced when the airways are subjected to tidal volume oscillations during contraction. In addition, airways contracted isovolumetrically at low volumes exhibit a markedly reduced sensitivity to submaximal concentrations of acetylcholine. This may limit bronchoconstriction at low lung volumes and transpulmonary pressures where the effectiveness of parenchymal stress in keeping the airways open is reduced. Together these factors could provide a mechanism by which bronchoconstriction is limited to low levels of airway resistance under normal conditions in vivo.
Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting
Walsh, Ryan R., Krismer, Florian , Galpern, Wendy R., Wenning, Gregor K. , Low, Phillip A. , Halliday, Glenda M. , Holton, Janice L. , Quinn, Niall , Rascol, Olivier , Shaw, Leslie M. , Eidelberg, David , Bower, Pam, Abler, Victor, Biedenharn, Judy, Bitan, Gal , Brundin, Patrik , Fernandez, Hubert, Fortier, Philip, Gasser, Thomas , Hewitt, Alice, Höglinger, Günter U. , Huentelman, Matt , Jensen, Poul Henning , Jeromin, Andreas, Kang, Un Jung , Kaufmann, Horacio , Kellerman, Lawrence R., Khurana, Vikram , Klockgether, Thomas , Kim, Woojin S. , Langer, Carol B., Masliah, Eliezer , Meissner, Wassilios G. , Ostrowitzki, Susanne, Piantadosi, Steven , Roemer, Cyndi, Schenk, Dale, Schlossmacher, Michael G. , Seppi, Klaus , Shih, Lily, Siderowf, Andrew , Stebbins, Glenn T. , Stefanova, Nadia , Sutton, Sharon Egretta, Zhang, Jing , Halliday, Glenda , Koroshetz, Walter J. , Holton, Janice, Quinn, Niall P, Brooks, David J. , Hewitt, Art, Huentelman, Matt J, Jensen, Poul H, Kellerman, Lawrence, Kim, Woojin Scott, Langer, Carol, LeWitt, Peter, Meissner, Wassilios, Melki, Ronald, Poewe, Werner, Schlossmacher, Michael, Schmahmann, Jeremy D, Tsuji, Shoji , Sutton, Sharon, Kaufmann, Horacio , Meissner, Wassilios G , Höglinger, Günter U , Krismer, Florian , Seppi, Klaus , Cummings, Jeffrey L. , Fortier, P, Freeman, Roy L. , LeWitt, Peter A. , Melki, Ronald , Poewe, Werner H , Robertson, David L. , Schmahmann, Jeremy Dan , Sutton, Sharon

Mayo Clinic

Neurology | December 13, 2017 | Volume: 90 | Issue: 2 | Pages: 74-82

10.1212/wnl.0000000000004798 | PMID 29237794 Get It

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)
O’Mahony, Constantinos , Jichi, Fatima, Ommen, Steve R. , Christiaans, Imke , Arbustini, Eloisa , García‐Pavía, Pablo , Olivotto, Iacopo , Kitaoka, Hiroaki , Gotsman, Israel , Carr‐White, Gerald, Mogensen, Jens , Antoniades, Loizos , Tang, Hak Chiaw , Geske, Jeffrey B. , Siontis, Konstantinos C. , Mahmoud, Karim D. , Vermeer, Alexa M.C. , Wilde, Arthur A.M. , Favalli, Valentina , Guttmann, Oliver , Gallego‐Delgado, María , Domínguez, Fernándo , Tanini, Ilaria , Kubo, Toru , Keren, Andre , Bueser, Teofila , Waters, Sarah, Issa, Issa Farah , Malcolmson, James , Burns, Tom, Sekhri, Neha, Hoeger, Christopher W. , Omar, Rumana , Elliott, Perry , Olivotto, Iacopo , Garcia-Pavia, Pablo , Geske, Jeffrey B , Cecchi, Franco , Mohiddin, Saidi , Maurer, Matthew J. , Dominguez, Fernando

Mayo Clinic

Circulation | November 30, 2017 | Volume: 137 | Issue: 10 | Pages: 1015-1023

10.1161/circulationaha.117.030437 | PMID 29191938 Get It

Background: Identification of people with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death (SCD) and require a prophylactic implantable cardioverter defibrillator is challenging. In 2014, the European Society of Cardiology proposed a new risk stratification method based on a risk prediction model (HCM Risk-SCD) that estimates the 5-year risk of SCD. The aim was to externally validate the 2014 European Society of Cardiology recommendations in a geographically diverse cohort of patients recruited from the United States, Europe, the Middle East, and Asia. Methods: This was an observational, retrospective, longitudinal cohort study. Results: The cohort consisted of 3703 patients. Seventy three (2%) patients reached the SCD end point within 5 years of follow-up (5-year incidence, 2.4% [95% confidence interval {CI}, 1.9–3.0]). The validation study revealed a calibration slope of 1.02 (95% CI, 0.93–1.12), C-index of 0.70 (95% CI, 0.68–0.72), and D-statistic of 1.17 (95% CI, 1.05–1.29). In a complete case analysis (n= 2147; 44 SCD end points at 5 years), patients with a predicted 5-year risk of <4% (n=1524; 71%) had an observed 5-year SCD incidence of 1.4% (95% CI, 0.8–2.2); patients with a predicted risk of ≥6% (n=297; 14%) had an observed SCD incidence of 8.9% (95% CI, 5.96–13.1) at 5 years. For every 13 (297/23) implantable cardioverter defibrillator implantations in patients with an estimated 5-year SCD risk ≥6%, 1 patient can potentially be saved from SCD. Conclusions: This study confirms that the HCM Risk-SCD model provides accurate prognostic information that can be used to target implantable cardioverter defibrillator therapy in patients at the highest risk of SCD.